FC
DNA icon

Financial Consulate’s Ginkgo Bioworks DNA Stock Holding History

Financial Consulate’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250
Closed -$3.65K – 1374
2025
Q3 		$3.65K Buy
+250
New +$2.99K ﹤0.01% 706
2023
Q2 		– Sell
-250
Closed -$13.3K – 63
2023
Q1 		$13.3K Hold
250
– – ﹤0.01% 123
2022
Q4 		$16.9K Hold
250
– – 0.01% 134
2022
Q3 		$31K Hold
250
– – 0.01% 117
2022
Q2 		$24K Hold
250
– – 0.01% 122
2022
Q1 		$40K Buy
+250
New +$48.7K 0.02% 130

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Consulate's DNA Position: Q4 2025 in Review

Financial Consulate sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 250 shares — an estimated $3.65K sold.

Financial Consulate first reported a position in DNA in Q1 2022 and held it in 6 quarters. The position peaked at $40K in Q1 2022. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Financial Consulate reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Financial Consulate sold 250 Ginkgo Bioworks shares in Q4 2025, an estimated $3.65K.
  • Financial Consulate first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 6 quarters.
  • Financial Consulate's Ginkgo Bioworks position peaked at $40K in Q1 2022.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Financial Consulate's 13F filing for Q4 2025, filed 22 Jan 2026.